REVISED 2023 OUTLOOKPrevious 2023 OutlookRevised 2023 Outlook (in millions except per share amounts) Total revenue$375 - $385$375 - $380 Adjusted consolidated EBITDA$110
Companies Reporting Before The Bell
• Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.
Gainers
Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.